EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Beyond one gene, one target: Next-generation precision oncology

Vivek Subbiah, Razelle Kurzrock

Trends in Cancer · 2026-07 · 12 (7) · 572-574

DOI: 10.1016/j.trecan.2026.06.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2026-07. Verfasst von Vivek Subbiah und 1 weiteren Autor:innen. Beteiligte Einrichtung: Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: viveksubbiah@stanford.edu. Hauptthemen laut MEDLINE: Precision Medicine, Neoplasms, Biomarkers, Tumor, Molecular Targeted Therapy. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Drug Rediscovery Protocol by K. Verkerk, et al., operationalized nationwide biomarker-guided, off-label precision oncology. Yet outcomes (15.7% response rate) mirror a decade of studies, indicating a single biomarker-drug strategy ceiling. Advancing efficacy will require customized, individualized combinations, consistent with the hallmarks of cancer complexity and the I-PREDICT (Investigation of profile-related evidence determining individualized cancer therapy) style clinical studies framework, which shows that outcomes scale with greater biomarker matching.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineNeoplasmsBiomarkers, TumorMolecular Targeted TherapyMedical OncologyAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsHumans

Stichwörter der Autor:innen

biomarkerscancergenomicsprecisiontargeted therapy

Substanzen

Biomarkers, TumorAntineoplastic Agents

Autor:innen und Institutionen

  • Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: viveksubbiah@stanford.edu.
  • Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin Cancer Center, Milwaukee, WI, USA; WIN Consortium, Paris, France. Electronic address: rkurzrock@mcw.edu.

Zitieren

APA

Subbiah, V., & Kurzrock, R. (2026). Beyond one gene, one target: Next-generation precision oncology. Trends in Cancer, 12(7), 572-574. https://doi.org/10.1016/j.trecan.2026.06.006

Vancouver

Subbiah V, Kurzrock R. Beyond one gene, one target: Next-generation precision oncology. Trends in Cancer. 2026;12(7):572-574. doi:10.1016/j.trecan.2026.06.006

BibTeX
@article{Subbiah2026,
  author = {Subbiah, Vivek and Kurzrock, Razelle},
  title = {Beyond one gene, one target: Next-generation precision oncology},
  journal = {Trends in Cancer},
  year = {2026},
  volume = {12},
  number = {7},
  pages = {572--574},
  doi = {10.1016/j.trecan.2026.06.006}
}
Kostenlos starten →